A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH)
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
This is a single-arm and open-label study of ATG-008 for the Treatment of Patients With
advanced Solid Tumors harboring NFE 2L2, STK11, RICTOR or other specific genetic alterationts